⌘K

Login Start Free

Home/Filings/4/0001209191-10-047394

4//SEC Filing

Trias Joaquim 4

Accession 0001209191-10-047394

CIK 0001316175other

View on SEC.gov Company Profile

Filed

Sep 22, 8:00 PM ET

Accepted

Sep 23, 8:44 PM ET

Size

7.2 KB

Accession

0001209191-10-047394

Insider Transaction Report

Form 4

Period: 2010-09-21

Anthera Pharmaceuticals IncANTH

SR VP, Preclinical Development

Transactions

Exercise/Conversion
Stock Option (right to buy)
2010-09-21−4,380→ 0 total
Exercise: $1.51From: 2009-04-15Exp: 2019-04-15→ Common Stock (4,380 underlying)
Exercise/Conversion
Common Stock
2010-09-21$1.51/sh+4,380$6,614→ 198,546 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Anthera Pharmaceuticals Inc

CIK 0001316175

Entity typeother

Related Parties

1

filerCIK 0001483998

Filing Metadata

Form type: 4
Filed: Sep 22, 8:00 PM ET
Accepted: Sep 23, 8:44 PM ET
Size: 7.2 KB

View on SEC.gov